Why the study?
Does urine detection of antihypertensive drugs by mass spectrometry provide a more accurate assessment of adherence compared to self-reported questionnaires in patients with treated essential hypertension?
Population
174 patients with treated essential hypertension attending an outpatient hypertension clinic of a university…
Comparison
Measurement of adherence to antihypertensive… vs Self-reported adherence using the four-item…
Design
Cohort
Follow-up
median 11 months (in a subpopulation of 105 patients)
Authors
Loading...
Urinary detection enables routine adherence monitoring in hypertension clinics; leaves open effects on BP outcomes in prospective trials.
Does urine detection of antihypertensive drugs by mass spectrometry provide a more accurate assessment of adherence compared to self-reported questionnaires in patients with treated essential hypertension?
Routine urine detection of antihypertensive drugs by mass spectrometry is an accurate and practical tool for monitoring adherence that provides information not captured by self-reported questionnaires.
Hamdidouche et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: